Print - Circulation
... therapy (10⫾15 shocks/patient, 26⫾33 months after implantation). The complication rate was 28%, including inappropriate shocks, which occurred in 45 patients (20%, 4⫾3 shocks/patient, 21⫾20 months after implantation). The reasons for inappropriate therapy were lead failure (19 patients), T-wave over ...
... therapy (10⫾15 shocks/patient, 26⫾33 months after implantation). The complication rate was 28%, including inappropriate shocks, which occurred in 45 patients (20%, 4⫾3 shocks/patient, 21⫾20 months after implantation). The reasons for inappropriate therapy were lead failure (19 patients), T-wave over ...
Severe Hypermagnesemia Resulting from Laxative
... Hypermagnesemia is an uncommon laboratory finding.5 Various disease states (Table 1) may either present with or result in mild increases in magnesium levels.6,7 Parathyroid hormone (PTH), calcitonin, glucagon, and vasopressin stimulate magnesium absorption in the TAL of the loop of Henle and the dis ...
... Hypermagnesemia is an uncommon laboratory finding.5 Various disease states (Table 1) may either present with or result in mild increases in magnesium levels.6,7 Parathyroid hormone (PTH), calcitonin, glucagon, and vasopressin stimulate magnesium absorption in the TAL of the loop of Henle and the dis ...
Teplizumab for treatment of type 1 diabetes (Protégé study): 1
... comparisons with placebo.17 However, because the primary outcome did not differ, subsequent analyses compared the 14‐day full‐dose regimen with placebo. These analyses were done for hypothesis generation, therefore no adjustment for multiple comparisons was made. Primary and secondary efficacy ana ...
... comparisons with placebo.17 However, because the primary outcome did not differ, subsequent analyses compared the 14‐day full‐dose regimen with placebo. These analyses were done for hypothesis generation, therefore no adjustment for multiple comparisons was made. Primary and secondary efficacy ana ...
Dr. Jack`s MedQuik Guide
... This publication is designed to provide general educational advice. It is provided to the reader with the understanding that Jack Krasuski and American Physician Institute for Advanced Professional Studies LLC are not rendering medical services. This guide is designed to aid physicians in exam prepa ...
... This publication is designed to provide general educational advice. It is provided to the reader with the understanding that Jack Krasuski and American Physician Institute for Advanced Professional Studies LLC are not rendering medical services. This guide is designed to aid physicians in exam prepa ...
Gouty Arthritis
... does not require dose adjustment in mild to moderate renal disease. Patients can also pay increased attention to diet and should be aware of new alternative agents (see below). Urate-lowering drugs are generally not initiated during acute attacks but after the patient is stable and low-dose colchici ...
... does not require dose adjustment in mild to moderate renal disease. Patients can also pay increased attention to diet and should be aware of new alternative agents (see below). Urate-lowering drugs are generally not initiated during acute attacks but after the patient is stable and low-dose colchici ...
RADIATION THERAPY ONCOLOGY GROUP RTOG 98
... hyperfractionated arms. This suggests that this group of patients may benefit even more from further dose escalation. Patients with anaplastic astrocytoma who received the higher hyperfractionated doses had worse survival than those receiving lower hyperfractionated doses. This suggests that at the ...
... hyperfractionated arms. This suggests that this group of patients may benefit even more from further dose escalation. Patients with anaplastic astrocytoma who received the higher hyperfractionated doses had worse survival than those receiving lower hyperfractionated doses. This suggests that at the ...
PDF - Hypertension
... igh blood pressure (BP) is the leading risk factor for premature death and disability-adjusted life years in the world.1 The development of a large pharmaceutical base from which to manage patients with hypertension in addition to many patient years of clinical trial experience have made it possible ...
... igh blood pressure (BP) is the leading risk factor for premature death and disability-adjusted life years in the world.1 The development of a large pharmaceutical base from which to manage patients with hypertension in addition to many patient years of clinical trial experience have made it possible ...
scope of practice - General Dental Council
... practise in accordance with the Council’s standards document ‘Standards for the Dental Team’ at all times. ...
... practise in accordance with the Council’s standards document ‘Standards for the Dental Team’ at all times. ...
Suboxone ® Agreement - Manhattan Pain Medicine
... (Suboxone), a prescription medication used to treat opioid addiction in the office-based setting. Suboxone is a medication that blocks other opioid drugs from attaching to opioid receptors in the brain, thereby decreasing the reinforcing effects of opioid drugs of abuse. It works by suppressing opio ...
... (Suboxone), a prescription medication used to treat opioid addiction in the office-based setting. Suboxone is a medication that blocks other opioid drugs from attaching to opioid receptors in the brain, thereby decreasing the reinforcing effects of opioid drugs of abuse. It works by suppressing opio ...
... Information technology is worthy of consideration in its own right as a prime mover of change, and not simply as a means to an end. White’s Medieval Technology and Social Change is a wonderful and short classic. The author, a distinguished historian, points out that most history is written by priest ...
Pr TECFIDERA™ - Biogen Canada
... infection of the brain caused by the JC virus (JCV) that typically only occurs in patients who are immunocompromised, and that usually leads to death or severe disability. During the clinical trial, the patient experienced prolonged lymphopenia (lymphocyte counts predominantly <0.5x109/L for 3.5 yea ...
... infection of the brain caused by the JC virus (JCV) that typically only occurs in patients who are immunocompromised, and that usually leads to death or severe disability. During the clinical trial, the patient experienced prolonged lymphopenia (lymphocyte counts predominantly <0.5x109/L for 3.5 yea ...
Pemphigoid - European Dermatology Forum
... Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localised or generalised bullous lesions. In up to 20% of affected patients bullae may be completely absent, and on ...
... Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localised or generalised bullous lesions. In up to 20% of affected patients bullae may be completely absent, and on ...
Management of malignant ventricular arrhythmias and cardiac arrest
... Support (23) have contributed to an increase in survival in patients with cardiac arrest. After the initial survey of airway, breathing, and circulation, rapid defibrillation is the most important predictor of subsequent survival from malignant ventricular arrhythmias (24). It has been estimated tha ...
... Support (23) have contributed to an increase in survival in patients with cardiac arrest. After the initial survey of airway, breathing, and circulation, rapid defibrillation is the most important predictor of subsequent survival from malignant ventricular arrhythmias (24). It has been estimated tha ...
... consecutively recruited 187 HIV-infected patients on combination antiretroviral therapy of two nucleoside analogues; stavudine and lamivudine and one nonnucleoside (nevirapine) was used. Association between the independent variables and adherence were analyzed using chi square analysis. Results: Thi ...
(PSD) November 2016 PBAC Meeting - (Word 228KB)
... provide access to vorinostat for three months to allow patients the opportunity to respond to treatment; agreed with the Pre-PBAC response’s (p3) claim that the aim of vorinostat treatment in the proposed PBS population was not curative, but to safely induce prolonged remission without adversely a ...
... provide access to vorinostat for three months to allow patients the opportunity to respond to treatment; agreed with the Pre-PBAC response’s (p3) claim that the aim of vorinostat treatment in the proposed PBS population was not curative, but to safely induce prolonged remission without adversely a ...
Tumor Necrosis Factor Alpha Inhibitors for Dermatologic Diseases
... psoriatic arthritis (Van Den Bosch et al., 2000). They were treated with infliximab 5 mg/kg at weeks 0, 2, 6, along with methotrexate. Rapid and significant improvement was noted in all patients without any significant side effects. PASI scores showed significant improvement at day 14 compared to ba ...
... psoriatic arthritis (Van Den Bosch et al., 2000). They were treated with infliximab 5 mg/kg at weeks 0, 2, 6, along with methotrexate. Rapid and significant improvement was noted in all patients without any significant side effects. PASI scores showed significant improvement at day 14 compared to ba ...
Methamphetamine, “Bath Salts,” and other Amphetamine
... Amphetamine, its analogues, and related derivatives have many deleterious cardiac effects with a significant incidence rate. Acute coronary syndrome (ACS) associated with AAD was first described by Orzel in 1982 [19,20]. This complication has been described in children and adults with varying corona ...
... Amphetamine, its analogues, and related derivatives have many deleterious cardiac effects with a significant incidence rate. Acute coronary syndrome (ACS) associated with AAD was first described by Orzel in 1982 [19,20]. This complication has been described in children and adults with varying corona ...
INTERNSHIP MANUAL *To be reviewed by Preceptor and Intern I
... This Internship Manual was updated extensively and contains the information and exercises that need to be discussed during the Internship Program. The answers to the scenarios at the end of this manual do not need to be forwarded to the College. They are for discussion and future reference of the In ...
... This Internship Manual was updated extensively and contains the information and exercises that need to be discussed during the Internship Program. The answers to the scenarios at the end of this manual do not need to be forwarded to the College. They are for discussion and future reference of the In ...
Scope of Practice - General Dental Council
... practise in accordance with the Council’s standards document ‘Standards for the Dental Team’ at all times. ...
... practise in accordance with the Council’s standards document ‘Standards for the Dental Team’ at all times. ...
imitrex nasal spray
... Myocardial Ischemia, Myocardial Infarction, and Prinzmetal’s Angina The use of IMITREX Nasal Spray is contraindicated in patients with ischemic or vasospastic CAD. There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours f ...
... Myocardial Ischemia, Myocardial Infarction, and Prinzmetal’s Angina The use of IMITREX Nasal Spray is contraindicated in patients with ischemic or vasospastic CAD. There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours f ...
PREHOSPITAL TREATMENT ALGORITHMS
... 2. Select proper size KING airway: size 3 for 4'-5', size 4 for 5'-6' and size 5 for >6' tall patient. 3. Assemble equipment, check cuffs for leaks, lubricate distal tip and posterior aspect ONLY. 4. Suction airway as needed and pre-oxygenate patient if possible. 5. For a trauma patient have assista ...
... 2. Select proper size KING airway: size 3 for 4'-5', size 4 for 5'-6' and size 5 for >6' tall patient. 3. Assemble equipment, check cuffs for leaks, lubricate distal tip and posterior aspect ONLY. 4. Suction airway as needed and pre-oxygenate patient if possible. 5. For a trauma patient have assista ...
Beneficial therapeutic effects of hemoperfusion
... or generally accepted guidelines are currently unavailable, and no optimal treatment has been established3,4. The basic treatment is the immediate withdrawal of all potentially responsible drugs. The principal clinical approaches include local management, fluid replacement, nutritional support, and ...
... or generally accepted guidelines are currently unavailable, and no optimal treatment has been established3,4. The basic treatment is the immediate withdrawal of all potentially responsible drugs. The principal clinical approaches include local management, fluid replacement, nutritional support, and ...
Product Monograph Template - Standard
... the concomitant use of other CNS depressant drugs with opioid analgesics (see DRUG INTERACTIONS). If the decision is made to prescribe a benzodiazepine or other CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use. In ...
... the concomitant use of other CNS depressant drugs with opioid analgesics (see DRUG INTERACTIONS). If the decision is made to prescribe a benzodiazepine or other CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use. In ...
PRINTER`S NO. 2081 THE GENERAL ASSEMBLY OF
... The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise: "Bona fide physician-patient relationship." ...
... The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise: "Bona fide physician-patient relationship." ...